Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-26 @ 4:42 PM
Study NCT ID:
NCT01058434
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2010-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
Sponsor:
Novartis Pharmaceuticals
Organization: